Unveiling the PDK4-centered rituximab-resistant mechanism in DLBCL: the potential of the "Smart" exosome nanoparticle therapy
揭示 DLBCL 中以 PDK4 为中心的利妥昔单抗耐药机制：“智能”外泌体纳米颗粒疗法的潜力
期刊:Molecular Cancer
影响因子:27.7
doi:10.1186/s12943-024-02057-0
Xin Wu, Chunmei Ban, Woding Deng, Xuewei Bao, Ning Tang, Yupeng Wu, Zhixuan Deng, Jianbin Xiong, Qiangqiang Zhao0
